| Retracted: The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac. | None |
| STAT3 the oncogene - still eluding therapy?. | None |
| STAT3 and HIF1alpha Signaling Drives Oncogenic Cellular Phenotypes in Malignant Peripheral Nerve Sheath Tumors. | None |
| Folic acid mediates activation of the pro-oncogene STAT3 via the Folate Receptor alpha. | None |
| Mitochondrial STAT3 contributes to transformation of Barrett s epithelial cells that express oncogenic Ras in a p53-independent fashion. | None |
| we have presented data supporting that STAT3beta is a tumor suppressor in ESCC, and STAT3beta can effectively suppress the oncogenic effects of STAT3alpha | None |
| SEA induces cell cross talk-dependent activation of STAT3 and expression of IL-17 in malignant T cells, suggesting a mechanism whereby SEA-producing bacteria promote activation of an established oncogenic pathway previously implicated in carcinogenesis. | None |
| findings reveal a new signaling axis downstream of the cytosolic DNA pathway and suggest potential interactions between innate immune responses and STAT3-driven oncogenic pathways | None |
| either oncogenic or a tumour suppressor [review] | None |
| Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. | None |
| STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. | None |
| Stat3 plays an important role in oncogenic Ros- and insulin-like growth factor I receptor-induced anchorage-independent growth. | None |